Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 13(8): e0203223, 2018.
Article in English | MEDLINE | ID: mdl-30169507

ABSTRACT

INTRODUCTION: Healthcare personnel are at high risk for exposure to influenza by direct and indirect contact, droplets and aerosols, and by aerosol generating procedures. Information on air and surface influenza contamination is needed to assist in developing guidance for proper prevention and control strategies. To understand the vulnerabilities of healthcare personnel, we measured influenza in the breathing zone of healthcare personnel, in air and on surfaces within a healthcare setting, and on filtering facepiece respirators worn by healthcare personnel when conducting patient care. METHODS: Thirty participants were recruited from an adult emergency department during the 2015 influenza season. Participants wore personal bioaerosol samplers for six hours of their work shift, submitted used filtering facepiece respirators and medical masks and completed questionnaires to assess frequency and types of interactions with potentially infected patients. Room air samples were collected using bioaerosol samplers, and surface swabs were collected from high-contact surfaces within the adult emergency department. Personal and room bioaerosol samples, surface swabs, and filtering facepiece respirators were analyzed for influenza A by polymerase chain reaction. RESULTS: Influenza was identified in 42% (53/125) of personal bioaerosol samples, 43% (28/ 96) of room bioaerosol samples, 76% (23/30) of pooled surface samples, and 25% (3/12) of the filtering facepiece respirators analyzed. Influenza copy numbers were greater in personal bioaerosol samples (17 to 631 copies) compared to room bioaerosol samples (16 to 323 copies). Regression analysis suggested that the amount of influenza in personal samples was approximately 2.3 times the amount in room samples (Wald χ2 = 16.21, p<0.001). CONCLUSIONS: Healthcare personnel may encounter increased concentrations of influenza virus when in close proximity to patients. Occupations that require contact with patients are at an increased risk for influenza exposure, which may occur throughout the influenza season. Filtering facepiece respirators may become contaminated with influenza when used during patient care.


Subject(s)
Emergency Service, Hospital , Health Personnel , Influenza, Human , Occupational Exposure , Air Microbiology , Cross-Sectional Studies , Humans , Influenza A virus , Influenza, Human/transmission , Masks/virology , Respiratory Protective Devices/virology
2.
J Occup Environ Hyg ; 15(9): 664-675, 2018 09.
Article in English | MEDLINE | ID: mdl-30081757

ABSTRACT

Increased understanding of influenza transmission is critical for pandemic planning and selecting appropriate controls for healthcare personnel safety and health. The goals of this pilot study were to assess environmental contamination in different areas and at two time periods in the influenza season and to determine the feasibility of using surgical mask contamination to evaluate potential exposure to influenza virus. Bioaerosol samples were collected over 12 days (two 6-day sessions) at 12 locations within a student health center using portable two-stage bioaerosol samplers operating 8 hr each day. Surface samples were collected each morning and afternoon from common high-contact non-porous hard surfaces from rooms and locations where bioaerosol samplers were located. Surgical masks worn by participants while in contact with patients with influenza-like illness were collected. A questionnaire administered to each of the 12 participants at the end of each workday and another at the end of each workweek assessed influenza-like illness symptoms, estimated the number of influenza-like illness patient contacts, hand hygiene, and surgical mask usage. All samples were analyzed using qPCR. Over the 12 days of the study, three of the 127 (2.4%) bioaerosol samples, 2 of 483 (0.41%) surface samples, and 0 of 54 surgical masks were positive for influenza virus. For the duration of contact that occurred with an influenza patient on any of the 12 days, nurse practitioners and physicians reported contacts with influenza-like illness patients >60 min, medical assistants reported 15-44 min, and administrative staff reported <30 min. Given the limited number of bioaerosol and surface samples positive for influenza virus in the bioaerosol and surface samples, the absence of influenza virus on the surgical masks provides inconclusive evidence for the potential to use surgical masks to assess exposure to influenza viruses. Further studies are needed to determine feasibility of this approach in assessing healthcare personnel exposures. Information learned in this study can inform future field studies on influenza transmission.


Subject(s)
Health Personnel , Influenza, Human/transmission , Masks/virology , Aerosols , Humans , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Maryland/epidemiology , Occupational Exposure , Orthomyxoviridae/genetics , Orthomyxoviridae/isolation & purification , Pilot Projects , RNA, Viral , Real-Time Polymerase Chain Reaction , Students , Surveys and Questionnaires , Workplace
3.
Influenza Other Respir Viruses ; 10(5): 404-13, 2016 09.
Article in English | MEDLINE | ID: mdl-26991074

ABSTRACT

BACKGROUND: To prepare for a possible influenza pandemic, a better understanding of the potential for the airborne transmission of influenza from person to person is needed. OBJECTIVES: The objective of this study was to directly compare the generation of aerosol particles containing viable influenza virus during coughs and exhalations. METHODS: Sixty-one adult volunteer outpatients with influenza-like symptoms were asked to cough and exhale three times into a spirometer. Aerosol particles produced during coughing and exhalation were collected into liquid media using aerosol samplers. The samples were tested for the presence of viable influenza virus using a viral replication assay (VRA). RESULTS: Fifty-three test subjects tested positive for influenza A virus. Of these, 28 (53%) produced aerosol particles containing viable influenza A virus during coughing, and 22 (42%) produced aerosols with viable virus during exhalation. Thirteen subjects had both cough aerosol and exhalation aerosol samples that contained viable virus, 15 had positive cough aerosol samples but negative exhalation samples, and 9 had positive exhalation samples but negative cough samples. CONCLUSIONS: Viable influenza A virus was detected more often in cough aerosol particles than in exhalation aerosol particles, but the difference was not large. Because individuals breathe much more often than they cough, these results suggest that breathing may generate more airborne infectious material than coughing over time. However, both respiratory activities could be important in airborne influenza transmission. Our results are also consistent with the theory that much of the aerosol containing viable influenza originates deep in the lungs.


Subject(s)
Aerosols/analysis , Air Microbiology , Cough/virology , Influenza A virus/physiology , Influenza, Human/transmission , Microbial Viability , Adult , Exhalation , Female , Humans , Influenza, Human/prevention & control , Influenza, Human/virology , Male , Pandemics/prevention & control , RNA, Viral , Spirometry , Virus Replication , Young Adult
4.
J Occup Environ Hyg ; 12(2): 107-13, 2015.
Article in English | MEDLINE | ID: mdl-25523206

ABSTRACT

Patients with influenza release aerosol particles containing the virus into their environment. However, the importance of airborne transmission in the spread of influenza is unclear, in part because of a lack of information about the infectivity of the airborne virus. The purpose of this study was to determine the amount of viable influenza A virus that was expelled by patients in aerosol particles while coughing. Sixty-four symptomatic adult volunteer outpatients were asked to cough 6 times into a cough aerosol collection system. Seventeen of these participants tested positive for influenza A virus by viral plaque assay (VPA) with confirmation by viral replication assay (VRA). Viable influenza A virus was detected in the cough aerosol particles from 7 of these 17 test subjects (41%). Viable influenza A virus was found in the smallest particle size fraction (0.3 µm to 8 µm), with a mean of 142 plaque-forming units (SD 215) expelled during the 6 coughs in particles of this size. These results suggest that a significant proportion of patients with influenza A release small airborne particles containing viable virus into the environment. Although the amounts of influenza A detected in cough aerosol particles during our experiments were relatively low, larger quantities could be expelled by influenza patients during a pandemic when illnesses would be more severe. Our findings support the idea that airborne infectious particles could play an important role in the spread of influenza.


Subject(s)
Aerosols/analysis , Air Microbiology , Cough/virology , Influenza A virus/isolation & purification , Influenza, Human/transmission , Adolescent , Adult , Female , Humans , Male , Particle Size , RNA, Viral/analysis , RNA, Viral/isolation & purification , Viral Plaque Assay , Virus Replication
5.
Bioorg Med Chem ; 21(17): 4923-7, 2013 Sep 01.
Article in English | MEDLINE | ID: mdl-23896610

ABSTRACT

A series of ring-constrained phenylpropyloxyethylamines, partial opioid structure analogs and derivatives of a previously studied sigma (σ) receptor ligand, was synthesized and evaluated at σ and opioid receptors for receptor selectivity. The results of this study identified several compounds with nanomolar affinity at both σ receptor subtypes. Compounds 6 and 9 had the highest selectivity for both σ receptor subtypes, compared to µ opioid receptors. In addition, compounds 6 and 9 significantly reduced the convulsive effects of cocaine in mice, which would be consistent with antagonism of σ receptors.


Subject(s)
Cyclohexanols/chemistry , Ethylamines/chemistry , Phenethylamines/chemistry , Propylamines/chemistry , Receptors, sigma/antagonists & inhibitors , Animals , Cocaine/chemistry , Cocaine/toxicity , Convulsants/chemistry , Convulsants/metabolism , Convulsants/therapeutic use , Cyclohexanols/metabolism , Cyclohexanols/therapeutic use , Ethylamines/metabolism , Ethylamines/therapeutic use , Mice , Phenethylamines/metabolism , Phenethylamines/therapeutic use , Propylamines/metabolism , Propylamines/therapeutic use , Protein Binding , Receptors, sigma/metabolism , Seizures/chemically induced , Seizures/drug therapy
6.
Curr Pharm Des ; 18(7): 902-19, 2012.
Article in English | MEDLINE | ID: mdl-22288407

ABSTRACT

Drug abuse is currently a large economic and societal burden in countries around the globe. Many drugs of abuse currently lack adequate therapies aimed at treating both the addiction and negative complications often associated with their use. Sigma-1 receptors were discovered over 30 years ago and have recently become targets for the development of pharmacotherapies aimed at treating substance abuse and addiction. In vivo preclinical studies have revealed that sigma receptor ligands are able to ameliorate select behavioral effects of many drugs of abuse including cocaine, methamphetamine, ethanol and nicotine. In addition, recent studies have begun to elucidate the mechanisms by which sigma-1 receptors modulate the effects of these drugs on neurotransmission, gene regulation and neuroplasticity. Overall, these recent findings suggest that compounds targeting sigma-1 receptors may represent a potential new class of therapeutics aimed at treating drug abuse. Future studies involving clinical populations will be critical for validating the therapeutic potential of sigma-1 receptor ligands for the treatment of substance abuse.


Subject(s)
Central Nervous System Agents/therapeutic use , Receptors, sigma/agonists , Receptors, sigma/antagonists & inhibitors , Substance-Related Disorders/drug therapy , Animals , Central Nervous System Agents/pharmacology , Humans , Sigma-1 Receptor
SELECTION OF CITATIONS
SEARCH DETAIL
...